Global IVF Devices and Consumables Market - 2022-2029

Market Overview

IVF Devices and Consumables Market size was valued US$ 2,147 million in 2021 and is estimated to reach US$ 19,844.83 billion by 2029, growing at a CAGR of 21.7% during the forecast period (2022-2029).

IVF is a type of assisted reproductive technology used for infertility treatment and gestational surrogacy. A fertilized egg may be implanted into a surrogate's uterus, and the resulting child is genetically unrelated to the surrogate. IVF is generally not used until less expensive and invasive options have failed or been determined unlikely to work. High success rates, live birth rates, rise in the infertile population are some of the drivers of the market.

Market Dynamics

The IVF devices and consumables market growth is driven by an increase in global infertility rates, increased number of sexually transmitted diseases, technological advancement associated with IVF devices, increase in the donation of gametes and new innovative launches.

Increasing global infertility rates and rising technological advancements are expected to drive the market growth.

Global IVF Devices and Consumables Market is driven by an increase in global infertility rates, increased number of sexually transmitted diseases, technological advancement associated with IVF devices.

An increase in global infertility rates is one of the dominating factors propelling the market. According to WHO, in 2019, 48.5 million couples ans 186 million individuals worldwide are unable to have a child. They found that 1.9 percent of women aged 20-44 who wanted a child were unable to have their first live birth and 10.5 percent of women who had previously given birth were unable to have another baby after five years of trying.

An increased number of sexually transmitted diseases is expected to boost the market. Sexually transmitted infections (STIs) like Chlamydia and gonorrhea are the leading preventable cause of infertility by causing 70% of pelvic inflammatory diseases (PID) responsible for tubal damage. Chlamydia can also cause fallopian tube infection without any symptoms. PID may also cause permanent damage to the fallopian tubes, uterus, and surrounding tissues, which can lead to infertility. CDC has estimated that around 2.86 million cases of Chlamydia and 820,000 cases of gonorrhea occur annually in the US. WHO reported that in 2019, more than 1 million sexually transmitted infections (STIs) are acquired every day.

Technological advancement in IVF devices is boosting the market. This is owing to the recent advances which have the potential to expand the utilization of IVF to a broad section of society with and without an infertility diagnosis. For instance, Vitrification, a flash or fast-freeze technology, has greatly improved outcomes from cryopreserved embryos. Patients using frozen embryos have success rates equal to, or better than, those from fresh embryo transfer cycles. Also, genetic disease screening involving embryo biopsy and genetic analysis, single embryo transfer, and new medications like gonadotropin-releasing hormone agonists are in use.

High cost associated with IVF devices and consumables is expected to hamper the market growth.

The high costs associated with IVF procedures, complications related to IVF treatment, and low awareness of IVF services are hampering the market growth. Direct costs per couple ranged from approximately $13,000 in the US to over $4,000 in the UK, Australia, Germany, and $112,799 in California.

Industry Analysis

The global IVF devices and consumables market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis, pricing analysis and unmet needs.

Segment Analysis

Instruments segment is expected to hold the largest market share in global IVF devices and consumables market

On the basis of products, the global IVF devices and consumables market is segmented into instruments, reagent & media, and accessory and disposables. The instrument segment is further divided into sperm separation system cryosystem, imaging system incubator, IVF cabinet, micromanipulator, and others. Reagent & media is sub-segmented into semen processing media, cryopreservation media, embryo culture media, ovum processing media.

Accessory & disposables segment is one of the dominating factors propelling the market over the forecast period. This is owing to its vital role in every IVF procedure, such as analysis & screening of sperms, retrieval of oocytes, handling of gametes, and others. For instance, sperm analysis accessory like Parallabs's Leja disposable slides has an optimised chamber depth for rapid loading, with even distribution and accuracy for semen samples. Vitrolife's vacuum pump tubing is intended for the connection between the needle and the vacuum pump during oocyte pick up and works as a natural extension for all follicle aspiration sets.

The instrument segment is expected to grow at a high rate over the forecast period. This is owing to the technological advancements and increase in demand for advanced IVF devices. For instance, Microfluidics technology known as SPARTAN helps in getting sperm with excellent motility, normal morphology, and better DNA integrity. INVOcell allowed IVF-created embryos to be incubated in a device that is placed in the woman's vagina before they are transferred to her uterus, was a new development that may make IVF more affordable option for more patients. The ability to freeze and thaw embryos successfully is one of the significant advancements in assisted reproductive technology (ART). New trends in assisted reproduction technology (ART) include Preimplantation genetic screening (PGS), preimplantation genetic diagnosis (PGD), egg vitrification, time lapse embryoscope, endometrial receptivity array (ERA).

Geographical Analysis

North America region holds the largest market share in the global IVF devices and consumables market

North America is dominating the global IVF devices and consumables market and is estimated to hold the largest market size over the forecast period. This is owing to higher live birth rates using ART, favorable reimbursement schemes, rising prevalence of sexually transmitted diseases like Chlamydia and gonorrhea in the region.

The presence of favorable reimbursement schemes, such as the implementation of USD 50 million 5-year plans by the US department of defense for sperm/egg freezing coverage, is expected to drive the market.

The rising prevalence of sexually transmitted diseases leading to increased government initiatives is expected to drive the market over the period of forecast. For instance, according to CDC, nearly 2.3 million cases of Chlamydia, gonorrhea, and syphilis were diagnosed in the US in 2019. It has been reported that there are few screening programs in the US such as all adults and adolescents from ages 13 to 64 should be tested at least once for HIV. Also, the US department of health and human services center for disease control and prevention (CDC) oversees and funds the prevention of sexually transmitted diseases (STDs).

An increase in infertility rates is leading to the raised demand for the installation of IVF devices in fertility clinics. For instance, according to the CDC, 12 percent of women in the US of age 15-44 are with infertility issues. In that same age group, 7.3 million American women have used infertility services. The development of SPARTAN, by a team of researchers from Worcester Polytechnic Institute (WPI) and Stanford University, is expected to reduce the overall cost of IVF treatments, which generally cost about $15,000 per cycle, because with the new sperm sorting technology they could be able to become pregnant without going through as many treatment cycles.

However, over the forecast period, Asia-Pacific is expected to dominate the global IVF devices and consumables market. The Asia Pacific initiative on reproduction (ASPIRE) consists of a task force of clinicians and scientists who are involved in monitoring and managing fertility and assisted reproductive technology (ART). Such initiatives are promoting awareness among consumers which is driving the growth of the global IVF and consumables market.

Competitive Landscape

Some of the major players in the global IVF devices and consumables market are Cook Medical Inc., IVF Store, Fujifilm Holdings Corporation, Merck KGaA, Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc.), Thermo Fisher Scientific, Inc., and Vitrolife AB.

The key players are adopting various key strategies such as product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the IVF devices and consumables market globally. For instance,

• In Jul 2021, Vitrolife AB announced its agreement for acquisition of Igenomix S.L. Igenomix 100% shares has been acquired by Vitrolife from EQT.
• In Dec 2021, Cooper companies announced the completion of acquisition of Generate Life Sciences, provides donor eggs and sperma for fertility cryopreservation and fertility treatments.
• In July 2022, Fujifilm Holdings Corporation launched embryo culture heavy oil. It is a mineral oil that provides sterility and optimal weight viscosity for proper balance between protection and easy use.
• In Jun 2022, Fujifilm Irvine announced that it has licensed intellectual property related with artificial intelligencefor evaluation of human embryos based on imaging.

Key Companies to Watch

Cook Medical Inc.:

Overview: Cook medical is a Cook Group Inc. subsidiary, company of medical device that manufactures and markets minimally invasive medicine devices. It provides services that includes anesthesiology, cardiothoracic surgery, neurosurgery, plastic surgery, urology, burn surgery, colorectal surgery and traumatology. Products provided are needles, catheters, stents, extractors, grafts and feeding tubes. It was founded in 1963 and is headquartered in Indiana, United States.

Product Portfolio:

Sydney IVF Blastocyst warming kits: These are the blastocyst warming kits that are used for human blastocysts that underwent verification with the help of IVF blastocyst verification kit.

Key Developments: In May 2022, Cook Medical announced its launch of MINC+ Benchtop incubator specially designed for IVF clinics in United States and Canada. It is a part of the system of assisted reproductive technology products.

The global IVF devices and consumables market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.